| Literature DB >> 29902895 |
Xiao-Lin Ma1,2,3, Wei-Xian Li2,3,4, Dong Wang2,3, Fu-Ping Lu1, Zhu-Bo Dai2,3, Xue-Li Zhang2,3.
Abstract
Hederagenin is an effective constituent of many medical plants, such as Clematidis Radix, and has a wide range of applications in anti-tumor, anti-inflammatory, antidepressant, hepatoprotective antibacterial, et al. In order to obtain the efficient production of yeast cells for hederagenin,we successfully cloned and screened out a P450 gene MdMA02 from Malus×domestica which can catalyze oleanolic acid C-23 oxidation with our developed plug and play platform. Its amino acid homology is only 32% as compared to characterized CYP72A68v2. By transforming MdMA02 to the oleanolic acid-producing strain BY-OA, a hederagenin-producing strain was constructed and hederagenin's titer could achieve 101 mg·L⁻¹ using high cell density fermentation, which was 337 times higher than in shake flasks culturing. This study provides a basis for further research on promoting the creation of oleanane-type pentacyclic triterpenoids biosynthetic pathway analysis and relative cell factories construction. Copyright© by the Chinese Pharmaceutical Association.Entities:
Keywords: Saccharomyces cerevisiae ; hederagenin ; oleanane type ; synthetic biology
Mesh:
Substances:
Year: 2018 PMID: 29902895 DOI: 10.19540/j.cnki.cjcmm.20180307.008
Source DB: PubMed Journal: Zhongguo Zhong Yao Za Zhi ISSN: 1001-5302